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Mowat-Wilson syndrome (OMIM 235730) is a genetic condition characterized by moderate-to-severe intellectual disability, a
recognizable facial phenotype, and multiple congenital anomalies. The striking facial phenotype in addition to other features
such as severely impaired speech, hypotonia, microcephaly, short stature, seizures, corpus callosum agenesis, congenital heart
defects, hypospadias, and Hirschsprung disease are particularly important clues for the initial clinical diagnosis. All molecularly
confirmed cases with typical MWS have a heterozygous loss-of-function mutation in the zinc finger E-box protein 2 (ZEB2)
gene, also called SIP1 (Smad-interacting protein 1) and ZFHX1B, suggesting that haploinsuﬃciency is the main pathological
mechanism. Approximately 80% of mutations are nonsense and frameshift mutations (small insertions or deletions). About half
of these mutations are located in exon eight. Here, we report the first Indonesian patient with Mowat-Wilson syndrome confirmed
by molecular analysis.
1. Introduction
Mowat-Wilson syndrome (MWS; OMIM 235730) is a rare
genetic condition described by Mowat et al. in 1998, who
reported a series of six children with intellectual disability
(ID), striking facial features, and variable multiple congenital
anomalies (MCA) [1]. All molecularly confirmed cases with
typical MWS have a heterozygous loss of function mutation
in the zinc finger E-box protein 2 (ZEB2) gene, also called
SIP1 (Smad-interacting protein 1) and ZFHX1B [2]. To date,
about 200 molecularly proven MWS cases with over 100
diﬀerent ZEB2 mutations have been reported [3].
The facial features are the most important diagnostic
clue for the initial clinical diagnosis and provide a hallmark
for ZEB2 mutation analysis [4]. Establishing a molecular
diagnosis is important for the patients and their families as it
allows reliable genetic counseling for their families and a bet-
ter clinical management of the patients. Here, we report the
first Indonesian patient with molecularly confirmed MWS.
2. Case Presentation
The patient was a nineteen-year-old male with severe ID. He
was the third son of nonconsanguineous, healthy, Javanese
parents and family history was unremarkable. The patient
was born at term after an uneventful pregnancy with a
weight of 3200 g (25th centile) and length 50 cm (50th
centile). He showed hypotonia and delayed developmental
milestones. He started to sit at 20 months of age. At two
years of age, he developed recurrent generalized seizures
and was commenced on valproic acid, which brought his
epilepsy under control. He started to walk at four years of
age and spoke his first words at the age of five years. He
had recurrent otitis media. Speech consisted of only a few
words and he often communicated using sign language. He
showed happy behavior with frequent smiling. In addition,
he showed repetitive hand movements. On physical exam-
ination, his weight was 45 kg (<3rd centile), height 161 cm
(<3rd centile), and head circumference 53 cm (<3rd centile).
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Figure 1: Photograph of Indonesian patient with Mowat-Wilson syndrome. Our patient in his 19 years of age showed striking facial gestalts
of MWS such as large eyebrows with medial flaring (a) and uplifted ear lobules (b). Other dysmorphisms such as long face, deep-set eyes,
upward slanting palpebral fissures, hypertelorism, strabismus, saddle nose with prominent rounded nasal tip, prominent columella, low-set
and posteriorly rotated ears, prominent and triangular pointed chin, small mouth, full lips, and prognathia are noted.
Facial dysmorphisms included a long face, deep-set eyes,
large eyebrows with medial flaring, hypertelorism, stra-
bismus, saddle nose with prominent rounded nasal tip,
prominent columella, low-set and posteriorly rotated ears,
uplifted ear lobules, a prominent narrow pointed chin, a
small mouth, and prognathism (Figure 1). In addition, he
had tapered and slender fingers, prominent interphalangeal
joints, and bilateral pes planus. Generalized hypotonia and
hyperreflexia were observed. Heart auscultation was normal.
The individual was part of a larger series of 527 Indone-
sian individuals with ID from schools and institutions,
whose conventional karyotyping, FMR1 gene analysis, and
subtelomeric MLPA were normal [5]. Based on the clinical
features, MWS was suspected. Therefore, molecular analysis
of the ZEB2 gene was warranted. Sanger sequencing of
all coding exons and surrounding splice sites of the ZEB2
gene was performed as described below. The genomic DNA
reference sequence was NM 014795.2. PCR of exon eight was
performed using primers CTTTACTTGGGTTTCCCACC
(forward) and GGGGCTTGTCATTCCTT (reverse). One
hundred nanograms of DNA solution (1 µL) were added into
PCRmixture, which contained 7.6 µL of 360 PCRmaster mix
(Applied Biosystem), 0.5 µL of primers working solution,
and 6 µL of H2O. Amplification was performed using
PCR System 9700 (Applied Biosystem) with the following
protocol. PCR was initiated by 10′ denaturation at 95◦C,
followed by 35 PCR cycles (30
′′
95◦C, 30′′ 60◦C, 60′′ 72◦C)
and 7′ final elongation at 72◦C. The result was analyzed on
ABI 3730 analyzer (Applied Biosystem). Sequence result was
compared to published reference sequence (rs148709333)
using SEQPilot software version 3.2.1.0 (JSI medical system).
In exon eight, a nonsensemutation has been detected, chang-
ing a TAC codon (coding for a tyrosine) into a TAG stop-
codon; c.1965C>G (p.(Tyr652∗)) (nomenclature according
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Figure 2: Electropherogram of molecular analysis in the patient
sample. The upper panel shows the heterozygous c.1965C>G
(p.Tyr652X) mutation and the lower panel shows the wild type
(control). The “S” on the electropherogram represents the C/G
heterozygote.
to the HGVS guidelines; http://www.hgvs.org/mutnomen/)
(Figure 2). To our knowledge, this mutation has not been
reported before.
3. Discussion
This is the first report of an Indonesian individual withMWS
confirmed by molecular genetic testing. Although nonsense
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Table 1: Clinical features of our patient compared to those in
published cases of MWS with proven ZEB2 mutations.
Clinical features Our patient
Mowat-Wilson
syndrome∗
ZEB2 mutations + 100%
Intellectual disability + 100%
Typical facial gestalt + 97%
Microcephaly + 81%
Seizures + 73%
HSCR −∗∗ 57%
CHD −∗∗ 52%
Hypospadias − 52%
Short stature + 46%
Hypoplasia or agenesis of CCA NT 43%
Cryptorchidism − 36%
Constipation − 26%
Pyloric stenosis − 4.7%
Eye anomalies − 4.1%
Cleft palate − 2.9%
∗
Adapted from Garavelli and Mainardi (2007) [4].
∗∗Symptoms not observed although the gold standard diagnosis has not
been performed.
NT: Not Tested, HSCR: Hirschprung Disease, CHD: Congenital Heart
Defect, CCA: Corpus Callosum.
mutations account for more than 40% of known ZEB2
mutations and approximately 50% of these are localized
in exon eight [6], the particular mutation detected in the
patient described in this paper (c.1965C>G; p.Tyr652∗) has
not been reported before.
Most clinical features of our patient, who had severe
ID, a distinct facial gestalt, microcephaly, and seizures, are
consistent with those described in the literature (Table 1).
Brain imaging and echocardiography could not be per-
formed since he is living in the country with minimal health
facilities. Symptoms of Hirschsprung disease (HSCR) such as
constipation, dysphagia, and poor appetite were not reported
in our patient, but the prevalence of these symptoms in
other publications ranged from the majority of individuals
[1, 2] to 50% of cases [4, 6]. Early diagnosis, intervention,
and targeted management are necessary for a better health
and life quality of individuals with MWS. However, as this
syndrome is rare and recently described, the knowledge
of the clinical complications and natural history is still
developing [7].
In summary, we report the first Indonesian MWS case
with a novel ZEB2 mutation. Our patient showed similar
dysmorphism to previously reported cases, although several
major associated features were not present such as HSCR,
congenital heart defect (CHD), and hypospadia. Despite the
availability of molecular diagnostic tests in several parts of
the world, the recognition of clinically well-defined syn-
dromes will remain very important in countries with limited
diagnostic facilities such as Indonesia. The publication of
cases with recognizable facial features is therefore of great
importance in order to make local pediatricians aware of
rare conditions likeMowat-Wilson syndrome, allowingmore
clinical diagnoses in the future.
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